Lineage Cell Therapeutics In shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $100k | 91k | 1.10 |
| 2023-09-30 | $101k | 85k | 1.18 |
| 2023-06-30 | $121k | 85k | 1.42 |
| 2023-03-31 | $134k | 89k | 1.50 |
| 2022-12-31 | $104k | 89k | 1.17 |
| 2022-03-31 | $94k | 61k | 1.54 |
| 2021-12-31 | $143k | 58k | 2.45 |
| 2021-09-30 | $292k | 116k | 2.52 |
| 2021-06-30 | $153k | 54k | 2.85 |
| 2021-03-31 | $103k | 44k | 2.35 |